Parnayavani swarasa as an adjuvant in the management of Sheetapitta w.s.r to Urticaria

A randomized controlled clinical study to evaluate the efficacy of Parnayavani swarasa as an adjuvant in the management of Sheetapitta w.s.r to Urticaria

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053565

Enrollment

Registered

2023-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients showing minimum of 3 classical clinical feature of Sheetapitta. 2. Patients of age group between 21 to 60 years will be included irrespective of their gender, religion, marital status and socioeconomical status. 3. Subjects who are willing to participate in the study by giving the written consent

Exclusion criteria

Exclusion criteria: 1.Patients having associative symptoms like vomiting, fever and suffering from any other infections or systemic disorders. 2.History of angioedema and other skin disease like psoriasis, eczema. 3.History of anaphylaxis to medicine. 4.Subjects who are pregnant and lactating. 5.Subjects who are not willing to participate in the study.

Design outcomes

Primary

Measure	Time frame
Decreased symptoms of Urticarial rashesTimepoint: 0th, 14th, 20th day	—

Secondary

Measure	Time frame
Reduction in AEC countTimepoint: 0th, 14th, 20th day	—

Countries

India

Contacts

Public ContactDr Sajitha k

Sri Sri college of Ayurvedic science and research

sajithak96@gmail.com9448415810

Outcome results